181 related articles for article (PubMed ID: 8543798)
1. flk2/flt3 ligand is a potent cofactor for the growth of primitive B cell progenitors.
Hunte BE; Hudak S; Campbell D; Xu Y; Rennick D
J Immunol; 1996 Jan; 156(2):489-96. PubMed ID: 8543798
[TBL] [Abstract][Full Text] [Related]
2. The flt3 ligand promotes the survival of primitive hemopoietic progenitor cells with myeloid as well as B lymphoid potential. Suppression of apoptosis and counteraction by TNF-alpha and TGF-beta.
Veiby OP; Jacobsen FW; Cui L; Lyman SD; Jacobsen SE
J Immunol; 1996 Oct; 157(7):2953-60. PubMed ID: 8816402
[TBL] [Abstract][Full Text] [Related]
3. Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells.
Drexler HG
Leukemia; 1996 Apr; 10(4):588-99. PubMed ID: 8618433
[TBL] [Abstract][Full Text] [Related]
4. Combined signaling through interleukin-7 receptors and flt3 but not c-kit potently and selectively promotes B-cell commitment and differentiation from uncommitted murine bone marrow progenitor cells.
Veiby OP; Lyman SD; Jacobsen SE
Blood; 1996 Aug; 88(4):1256-65. PubMed ID: 8695843
[TBL] [Abstract][Full Text] [Related]
5. Flt3 ligand supports the differentiation of early B cell progenitors in the presence of interleukin-11 and interleukin-7.
Ray RJ; Paige CJ; Furlonger C; Lyman SD; Rottapel R
Eur J Immunol; 1996 Jul; 26(7):1504-10. PubMed ID: 8766553
[TBL] [Abstract][Full Text] [Related]
6. Differential ability of flt3-ligand, interleukin-11, and Steel factor to support the generation of B cell progenitors and myeloid cells from primitive murine fetal liver cells.
Lemieux ME; Chappel SM; Miller CL; Eaves CJ
Exp Hematol; 1997 Aug; 25(9):951-7. PubMed ID: 9257808
[TBL] [Abstract][Full Text] [Related]
7. Distinct actions of Flt3 ligand and stem cell factor on myeloid lineage selection and maturation of granulocytes versus macrophages.
Dannaeus K; Nilsson K; Jönsson JI
Exp Hematol; 1998 Apr; 26(4):345-52. PubMed ID: 9546318
[TBL] [Abstract][Full Text] [Related]
8. Thrombopoietin directly and potently stimulates multilineage growth and progenitor cell expansion from primitive (CD34+ CD38-) human bone marrow progenitor cells: distinct and key interactions with the ligands for c-kit and flt3, and inhibitory effects of TGF-beta and TNF-alpha.
Ramsfjell V; Borge OJ; Cui L; Jacobsen SE
J Immunol; 1997 Jun; 158(11):5169-77. PubMed ID: 9164933
[TBL] [Abstract][Full Text] [Related]
9. Differentiation of NK1.1+, Ly49+ NK cells from flt3+ multipotent marrow progenitor cells.
Williams NS; Klem J; Puzanov IJ; Sivakumar PV; Bennett M; Kumar V
J Immunol; 1999 Sep; 163(5):2648-56. PubMed ID: 10453005
[TBL] [Abstract][Full Text] [Related]
10. Modulation of haematopoietic progenitor development by FLT-3 ligand.
Banu N; Deng B; Lyman SD; Avraham H
Cytokine; 1999 Sep; 11(9):679-88. PubMed ID: 10479404
[TBL] [Abstract][Full Text] [Related]
11. Effects of Flt3 ligand and interleukin-7 on in vitro growth of acute lymphoblastic leukemia cells.
Eder M; Hemmati P; Kalina U; Ottman OG; Hoelzer D; Lyman SD; Ganser A
Exp Hematol; 1996 Feb; 24(2):371-7. PubMed ID: 8641368
[TBL] [Abstract][Full Text] [Related]
12. The effects of human FLT3 ligand on in vitro human megakaryocytopoiesis.
Piacibello W; Garetto L; Sanavio F; Severino A; Fubini L; Stacchini A; Dragonetti G; Aglietta M
Exp Hematol; 1996 Feb; 24(2):340-6. PubMed ID: 8641363
[TBL] [Abstract][Full Text] [Related]
13. Bidirectional effect of interleukin-10 on early murine B-cell development: stimulation of flt3-ligand plus interleukin-7-dependent generation of CD19(-) ProB cells from uncommitted bone marrow progenitor cells and growth inhibition of CD19(+) ProB cells.
Veiby OP; Borge OJ; Mârtensson A; Beck EX; Schade AE; Grzegorzewski K; Lyman SD; Mârtensson IL; Jacobsen SE
Blood; 1997 Dec; 90(11):4321-31. PubMed ID: 9373243
[TBL] [Abstract][Full Text] [Related]
14. The flt3 ligand supports proliferation of lymphohematopoietic progenitors and early B-lymphoid progenitors.
Hirayama F; Lyman SD; Clark SC; Ogawa M
Blood; 1995 Apr; 85(7):1762-8. PubMed ID: 7703483
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of c-Fos induces apoptosis of CD43+ pro-B cells.
Hu L; Hatano M; Rüther U; Tokuhisa T
J Immunol; 1996 Nov; 157(9):3804-11. PubMed ID: 8892609
[TBL] [Abstract][Full Text] [Related]
16. Stem cell factor, but not flt3 ligand, induces differentiation and activation of human mast cells.
Hjertson M; Sundström C; Lyman SD; Nilsson K; Nilsson G
Exp Hematol; 1996 May; 24(6):748-54. PubMed ID: 8635531
[TBL] [Abstract][Full Text] [Related]
17. Expansion of human NOD/SCID-repopulating cells by stem cell factor, Flk2/Flt3 ligand, thrombopoietin, IL-6, and soluble IL-6 receptor.
Ueda T; Tsuji K; Yoshino H; Ebihara Y; Yagasaki H; Hisakawa H; Mitsui T; Manabe A; Tanaka R; Kobayashi K; Ito M; Yasukawa K; Nakahata T
J Clin Invest; 2000 Apr; 105(7):1013-21. PubMed ID: 10749580
[TBL] [Abstract][Full Text] [Related]
18. Flt3/Flk-2 and c-Kit are not essential for the proliferation of B lymphoid progenitor cells in the bone marrow of the adult mouse.
Ogawa M; Sugawara S; Kunisada T; Sudo T; Hayashi S; Nishikawa S; Kodama H; Nishikawa S
Exp Hematol; 1998 Jun; 26(6):478-88. PubMed ID: 9620281
[TBL] [Abstract][Full Text] [Related]
19. The FLK2/FLT3 ligand synergizes with interleukin-7 in promoting stromal-cell-independent expansion and differentiation of human fetal pro-B cells in vitro.
Namikawa R; Muench MO; de Vries JE; Roncarolo MG
Blood; 1996 Mar; 87(5):1881-90. PubMed ID: 8634436
[TBL] [Abstract][Full Text] [Related]
20. Reduction of early B lymphocyte precursors in transgenic mice overexpressing the murine heat-stable antigen.
Hough MR; Chappel MS; Sauvageau G; Takei F; Kay R; Humphries RK
J Immunol; 1996 Jan; 156(2):479-88. PubMed ID: 8543797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
